查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997146

口服補液鹽市場：2026-2032年全球市場預測（依劑型、年齡層、應用、最終用戶及通路分類）

Oral Rehydration Salts Market by Form, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，口服補液鹽市場價值將達到 36.1 億美元，到 2026 年將成長至 39.3 億美元，到 2032 年將達到 66.3 億美元，年複合成長率為 9.04%。

主要市場統計數據
基準年 2025 36.1億美元
預計年份：2026年 39.3億美元
預測年份 2032 66.3億美元
複合年成長率 (%) 9.04%

口服補液鹽的策略性引入：涵蓋臨床意義、產品形式的演變、分銷現​​狀和相關人員的決策因素

口服補液鹽（ORS）處於臨床醫學、人道援助和消費者健康領域的交匯點，是治療急性腸胃炎、霍亂和運動性體液流失引起的脫水的基礎治療方法。儘管其配方簡單，但其供應和臨床應用卻受到生產規範、監管合規性和分銷物流等諸多複雜因素的影響。隨著時間的推移，包裝和即用型產品的創新已使其應用範圍從醫療機構擴展到社區和居家照護場所。同時，臨床指引仍強調口服補液鹽是治療輕度至中度脫水的首選療法。

對包裝創新、監管重點和供應鏈韌性驅動的、重塑口服補液鹽的關鍵結構和營運變化進行詳細分析。

口服補液鹽（ORS）領域正經歷變革，這主要得益於配方和包裝的創新、對本地可及性的持續重視以及全球供應鏈的重組。即用型液體ORS和單劑量包裝袋的進步提高了非臨床環境下的便利性，從而擴大了其在居家照護和大規模緊急應變場景中的應用。同時，數位化通路和遠端醫療轉診正在改變採購行為，使得直接向消費者交付和快速履約成為製造商和經銷商競爭的重點。

本研究全面檢驗了2025 年關稅變化將如何推動整個口服補液鹽 (ORS) 市場的供應鏈重組、籌資策略和產品設計決策。

2025年計畫實施的關稅及貿易政策調整將對口服補液鹽（ORS）產品中使用的電解質、預混合料和初級包裝的生產經濟效益和全球籌資策略產生重大影響。關稅帶來的成本壓力促使製造商重新評估供應商選擇，考察近岸外包機會，並重新談判長期採購合約以穩定投入成本。因此，一些公司正在加快投資建設國內即用型液體填充產能，而另一些公司則在尋找替代原料供應商，以減輕關稅波動的影響，同時滿足品質和合規標準。

從形式、管道、最終用途、應用和年齡層等方面揭示差異的深刻細分觀點，為產品設計和商業化策略提供指南。

細分市場分析揭示了產品和通路的微妙動態，這些動態可直接用於產品開發和商業策略。就劑型而言，口服補液鹽 (ORS) 產品組合涵蓋粉末和即用型液體兩種劑型。對於粉劑產品，散裝產品與預填充袋和小袋並存，其中小袋又細分為 1 克、2 克和 4 克三種規格。這些規格滿足了給藥便利性、兒童用藥以及大量分銷的物流需求。這些差異會影響生產線設計、包裝器材投資以及廢棄物管理的考量，尤其是在一次性廢棄物和環境影響至關重要的情況下。

區域洞察揭示了供應鏈、法規和分銷基礎設施如何影響世界各地市場的產品選擇和取得。

區域趨勢差異顯著，受當地疾病負擔、生產能力、法律規範和分銷基礎設施的影響。在美洲，完善的醫療採購系統和廣泛的零售網路支援粉劑和即用型製劑的廣泛供應，而公共衛生機構通常會協調大規模採購以應對感染疾病疫情。相較之下，歐洲、中東和非洲地區則呈現出監管嚴格和資源匱乏並存的複雜環境。各國監管機構和非政府組織採購通訊協定之間的協調一致對產品接受度至關重要，而小袋包裝和緊湊型包裝由於某些地區面臨的物流挑戰而顯得尤為重要。

以公司為中心的策略分析揭示了對創新、夥伴關係和供應鏈的投資如何決定競爭優勢和業務永續營運。

口服補液鹽（ORS）價值鏈上的主要企業正透過產品創新、策略夥伴關係和供應鏈投資相結合的方式，確保自身獲得競爭優勢。製造商優先考慮透過改進包裝袋和即用型製劑的化學成分，提高產品的穩定性和易用性，從而減少臨床和社區環境中的配製錯誤，並縮短給藥時間。同時，多家公司正在加強與公共衛生組織和人道主義援助供應商的合作，以確保在感染疾病爆發和緊急情況下能夠快速部署，從而在維護企業聲譽的同時，保障大規模生產的持續性。

為領導者提供可操作且優先考慮的建議，以加強與採購、產品系列、分銷和監管機構的合作，從而確保韌性和成長。

產業領導者應採取整合策略，協調產品設計、採購彈性和通路執行。首先，應實現原料和包裝材料供應來源多元化，包括地域分散且通過品質認證的供應商，並採用條件性採購協議，以便在不影響合規性的前提下快速替換供應商。其次，應優先調整產品系列，以便更能滿足終端用戶需求。具體而言，這意味著要拓展產品選擇，例如兒童袋裝配方和居家照護即用型產品，同時保留針對醫院採購最佳化的散裝和預填充產品。第三，應加強數位化和零售通路的能力，以滿足患者的需求，並支持藥房層面的教育，確保正確使用。

對構成分析和建議基礎的嚴格的一級和二級調查方法、供應鏈審計、臨床發現和三角驗證技術進行透明的解釋。

本研究途徑結合了專家和從業人員的結構化訪談、對監管和技術標準的系統性回顧以及有針對性的供應鏈分析，以檢驗採購風險和生產限制因素。主要資訊透過對臨床醫生、醫院採購負責人、包裝工程師和經銷商的訪談收集，並輔以工廠參觀和產品審核，以評估填充和包裝能力以及包裝適用性。次要研究包括分析臨床指導文件、成分專論和公共衛生採購框架，以建立臨床和監管預期基準。

透過將臨床意義、營運影響和策略重點整合到簡潔的結論中，我們指導決策者採取有韌性和有效的行動。

總之，口服補液鹽仍然是重要的治療和公共衛生產品，其未來發展方向將取決於產品創新、通路現代化和供應鏈韌性。包裝和配方方面的突破性進展使其能夠應用於更廣泛的場景，包括居家照護和運動領域。同時，貿易政策和法規的變化正在促使生產和採購資源進行策略性重新配置。在產品、通路和地理等各個方面，決策者都必須在臨床療效和營運需求之間取得平衡，以確保永續供應，並支援在感染疾病爆發期間的快速回應。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 口服補液鹽市場：依劑型分類

  • 粉末
    • 大部分
    • 預填充袋
    • 小袋
      • 1公克獨立包裝
      • 2克小包裝
      • 4克小包裝
  • 即用型液體

第9章 口服補液鹽市場：依年齡層別分類

  • 成人版
  • 兒童

第10章 口服補液鹽市場：依應用領域分類

  • 霍亂治療
  • 腹瀉管理
  • 體育運動

第11章 口服補液鹽市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院

第12章 口服補液鹽市場：依通路分類

  • 醫院藥房
  • 線上管道
  • 零售藥房
  • 超級市場和大賣場

第13章 口服補液鹽市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 口服補液鹽市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 口服補液鹽市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國口服補液鹽市場

第17章：中國口服補液鹽市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Bayer AG
  • Beximco Pharmaceuticals Limited
  • Cipla Limited
  • Daksh Pharmaceuticals Pvt. Ltd.
  • Danone SA
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Kenvue Inc.
  • Macleods Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Nestle SA
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • PepsiCo, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Limited
  • Unilever PLC
  • Viatris Inc.
Product Code: MRR-8A3707308FF6

The Oral Rehydration Salts Market was valued at USD 3.61 billion in 2025 and is projected to grow to USD 3.93 billion in 2026, with a CAGR of 9.04%, reaching USD 6.63 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.61 billion
Estimated Year [2026] USD 3.93 billion
Forecast Year [2032] USD 6.63 billion
CAGR (%) 9.04%

A strategic introduction to oral rehydration salts that frames clinical importance, evolving product formats, distribution realities, and stakeholder decision drivers

Oral rehydration salts (ORS) sit at the intersection of clinical medicine, humanitarian response, and consumer health, serving as a foundational intervention for dehydration resulting from acute gastroenteritis, cholera, and exertional fluid loss. The formulation simplicity belies significant complexity across manufacturing specifications, regulatory compliance, and distribution logistics that shape product availability and clinical adoption. Over time, innovations in packaging and ready-to-use formats have broadened access beyond clinical walls into community and home-care settings, while clinical guidelines continue to emphasize ORS as first-line therapy for mild to moderate dehydration.

In practice, product form and delivery channel influence clinical use patterns and procurement decisions. Based on form, the landscape is studied across powder and ready-to-use liquid, with powder further differentiated into bulk, prefilled pouch, and sachet formats; sachets themselves are typically available in 1 gram, 2 gram, and 4 gram variants tailored to dosage convenience and waste reduction. Equally important, distribution channels range from hospital pharmacies and retail pharmacies to supermarkets, hypermarkets, and the growing online channel, each imposing distinct stocking, regulatory, and margin considerations. As a consequence, stakeholders from clinicians to procurement specialists must balance clinical effectiveness with supply chain resilience and user acceptability.

Detailed analysis of the pivotal structural and operational shifts reshaping oral rehydration salts driven by packaging innovation, regulatory focus, and supply chain resilience

The ORS landscape is undergoing transformative shifts driven by innovation in formulation and packaging, continued emphasis on community-level access, and a reconfiguration of global supply chains. Advances in ready-to-use liquid ORS and single-dose sachets have improved usability in non-clinical settings, thereby expanding adoption in home care and mass-response scenarios. At the same time, digital channels and telehealth referrals have altered procurement behavior, making direct-to-consumer availability and rapid fulfillment a competitive priority for manufacturers and distributors.

Furthermore, regulatory pressures and heightened scrutiny of excipient sourcing have stimulated manufacturers to invest in traceability, quality assurance, and localized production capacity. In parallel, climate-related disruptions and elevated freight volatility have prompted buyers to diversify supplier networks and to consider packaging that reduces transportation weight and storage constraints. Consequently, the competitive calculus now includes not only clinical efficacy and price but also supply chain resilience, sustainability credentials, and the agility to support emergency public health deployments. These shifts are reshaping product roadmaps, R&D priorities, and commercial models across the value chain.

Comprehensive examination of how 2025 tariff changes catalyze supply chain reconfiguration, sourcing strategies, and product design decisions across the oral rehydration salts landscape

The introduction of tariffs and trade policy adjustments in 2025 has had material implications for the production economics and global sourcing strategies for electrolytes, premix components, and primary packaging used in ORS products. Tariff-induced cost pressures have encouraged manufacturers to reassess supplier footprints, evaluate nearshoring opportunities, and renegotiate long-term procurement agreements to stabilize input costs. As a result, some companies are accelerating investments in domestic filling capacity for ready-to-use liquids while others are exploring alternative ingredient suppliers that meet quality and compliance standards but reduce exposure to tariff volatility.

In addition, tariffs have prompted distributors and hospital procurement teams to revisit inventory strategies and contractual terms to preserve continuity of supply. Transitional measures include expanded safety stocks, conditional sourcing agreements, and collaborative forecasting with suppliers. Importantly, these adaptations are not purely tactical; they are influencing longer-term capital allocation and product design choices. For instance, packaging that reduces weight and volume can lower landed costs under tariff regimes, and modular manufacturing approaches enable faster adaptation to shifting trade landscapes. Thus, the cumulative effect of tariff policy is accelerating structural changes in supply chain design and commercial prioritization across the ORS ecosystem.

Insightful segmentation perspective that decodes form, channel, end-use, application, and age-driven distinctions to inform product design and commercialization strategies

Segmentation analysis reveals nuanced product and channel dynamics that directly inform product development and commercial strategy. By form, the ORS portfolio is examined across powder and ready-to-use liquid formats; within powder, bulk presentations coexist with prefilled pouches and sachets, and sachets are further differentiated into 1 gram, 2 gram, and 4 gram sizes that address dosing simplicity, pediatric administration, and logistics of mass distribution. These distinctions have implications for manufacturing line design, packaging machinery investment, and waste management considerations, particularly in contexts where single-use waste and environmental footprint are scrutinized.

Distribution channel segmentation shows divergent pathways for product reach and margin capture, with hospital pharmacies, retail pharmacies, supermarkets and hypermarkets, and online channels each demanding tailored packaging sizes, labeling conventions, and replenishment cadences. End-user segmentation identifies discrete use cases across clinics, home care, and hospitals, and these settings shape product configuration, education needs, and post-sale support. Application-driven segmentation highlights the roles of ORS in cholera treatment, diarrhea management, and sports and exercise recovery, necessitating different messaging and pharmacist or clinician engagement strategies. Finally, age-group differentiation into adult and pediatric formulations requires precise taste-masking, dosing guidance, and regulatory considerations, which in turn influence clinical acceptance and procurement preferences. Taken together, these segmentation layers should guide portfolio prioritization and channel-specific commercialization plans.

Regionally differentiated insights that illuminate how supply chain, regulation, and distribution infrastructure shape product choice and access across global markets

Regional dynamics vary considerably, influenced by local disease burden, manufacturing capacity, regulatory frameworks, and distribution infrastructure. In the Americas, established healthcare procurement systems and sizeable retail footprints support broad access to both powder and ready-to-use formulations, while public health agencies often coordinate large-volume acquisition for outbreak responses. Conversely, Europe, Middle East & Africa presents a heterogeneous mix of high-regulation environments and resource-constrained settings; regulatory alignment across national bodies and NGO procurement protocols plays a central role in product acceptance, and logistical challenges in certain geographies make sachet formats and compact packaging especially valuable.

Asia-Pacific serves as both a major manufacturing hub for ingredients and finished ORS products and as a fast-evolving commercial market with rising consumer awareness of pediatric and sports-related hydration needs. In many APAC countries, local manufacturers are investing in prefilled pouch technology and expanding distribution through digital marketplaces. Across regions, differences in cold chain requirements, import rules, and public procurement practices necessitate region-specific strategies for regulatory engagement, production planning, and distribution partnerships. Therefore, regional insight must drive tailored supply chain design and commercial approaches to ensure product availability and clinical uptake.

Strategic company-focused analysis revealing how innovation, partnerships, and supply chain investments are defining competitive positioning and operational resilience

Leading companies in the ORS value chain are pursuing a combination of product innovation, strategic partnerships, and supply chain investments to secure competitive advantage. Manufacturers are prioritizing stability and ease-of-use improvements through enhanced sachet chemistry and ready-to-use formulations that reduce preparation errors and shorten administration time in clinical and community settings. At the same time, several firms are forging collaborations with public health organizations and humanitarian suppliers to ensure rapid deployment during outbreaks and emergencies, supporting both reputation and volume-based production continuity.

Commercially, players are diversifying channel strategies to capture demand across hospital pharmacy procurement, retail and supermarket networks, and rapidly expanding online channels. Private label and contract manufacturing arrangements are increasing as global distributors seek cost-effective supply and as regional producers scale to meet localized demand. Moreover, an emphasis on traceability, compliance, and eco-design is influencing capital expenditures, with investments in recyclable packaging and minimized transport weight seen as both cost and sustainability levers. Competitive positioning is therefore defined by the ability to combine clinical credibility, operational resilience, and channel-specific go-to-market capabilities.

Practical and prioritized recommendations for leaders to strengthen sourcing, product portfolios, distribution, and regulatory engagement to secure resilience and growth

Industry leaders should pursue integrated strategies that align product design, sourcing resilience, and channel execution. First, diversify ingredient and packaging supply bases to include geographically dispersed, quality-certified suppliers and to adopt conditional sourcing agreements that enable rapid substitution without compromising compliance. Second, prioritize product portfolio adjustments that reflect end-user needs: expand pediatric-oriented sachet dosing and ready-to-use options for home care, while maintaining bulk and prefilled formats optimized for hospital procurement. Third, strengthen digital and retail channel capabilities to capture patient-directed demand and to support pharmacy-level education that ensures correct use.

In parallel, organizations should invest in sustainability measures that reduce transport weight and packaging waste, a move that also mitigates tariff and logistics pressures. Engage early with regulatory authorities to expedite approvals for reformulated products and to harmonize labeling requirements for cross-border distribution. Finally, develop scenario-based inventory and distribution playbooks to maintain continuity during trade disruptions or outbreak-driven surges. These coordinated actions will enable faster response to public health needs, protect margins under shifting trade conditions, and secure long-term commercial viability.

Transparent description of rigorous primary and secondary research methods, supply chain audits, clinical input, and triangulation techniques underpinning the analysis and recommendations

The research approach combined structured primary engagements with subject-matter experts and practitioners, systematic review of regulatory and technical standards, and targeted supply chain mapping to validate sourcing risks and manufacturing constraints. Primary inputs were gathered through interviews with clinicians, hospital procurement officers, packaging engineers, and distributors, supplemented by plant visits and product audits that assessed fill-finish capabilities and packaging compatibility. Secondary research included analysis of clinical guidance documents, ingredient monographs, and public health procurement frameworks to establish baseline clinical and regulatory expectations.

Data triangulation and cross-validation techniques were applied to reconcile qualitative insights with observed supply chain configurations and product portfolios. Where direct measurement was not feasible, scenario analysis and sensitivity checks were conducted to explore plausible operational responses to trade and logistics disruptions. Limitations of the study are acknowledged, including variable transparency in private procurement contracts and the rapidly evolving trade policy context; however, methodological safeguards and diversified sources provide a robust foundation for the strategic insights and recommendations offered.

Concise conclusion synthesizing clinical significance, operational implications, and strategic priorities to guide decision-makers toward resilient and effective action

In conclusion, oral rehydration salts continue to be an essential therapeutic and public health commodity whose future trajectory will be shaped by product innovation, distribution modernization, and supply chain resilience. Transformative packaging and formulation advances are enabling broader access across home care and athletic use cases, while trade policy and regulatory shifts are prompting strategic reallocation of manufacturing and sourcing resources. Across product, channel, and regional dimensions, decision-makers must balance clinical efficacy with operational imperatives to ensure sustained availability and to support rapid response during outbreaks.

Ultimately, the most successful organizations will be those that integrate clinical credibility with agile manufacturing, diversified sourcing, and channel-specific commercialization. By proactively adopting the recommendations outlined and by engaging with stakeholders across procurement, clinical, and regulatory functions, leaders can secure both short-term continuity and long-term competitive advantage in the evolving ORS landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oral Rehydration Salts Market, by Form

  • 8.1. Powder
    • 8.1.1. Bulk
    • 8.1.2. Prefilled Pouch
    • 8.1.3. Sachet
      • 8.1.3.1. 1 Gram Sachet
      • 8.1.3.2. 2 Gram Sachet
      • 8.1.3.3. 4 Gram Sachet
  • 8.2. Ready-To-Use Liquid

9. Oral Rehydration Salts Market, by Age Group

  • 9.1. Adult
  • 9.2. Pediatric

10. Oral Rehydration Salts Market, by Application

  • 10.1. Cholera Treatment
  • 10.2. Diarrhea Management
  • 10.3. Sports & Exercise

11. Oral Rehydration Salts Market, by End User

  • 11.1. Clinic
  • 11.2. Home Care
  • 11.3. Hospital

12. Oral Rehydration Salts Market, by Distribution Channel

  • 12.1. Hospital Pharmacy
  • 12.2. Online Channel
  • 12.3. Retail Pharmacy
  • 12.4. Supermarket & Hypermarket

13. Oral Rehydration Salts Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Oral Rehydration Salts Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Oral Rehydration Salts Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Oral Rehydration Salts Market

17. China Oral Rehydration Salts Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Bayer AG
  • 18.7. Beximco Pharmaceuticals Limited
  • 18.8. Cipla Limited
  • 18.9. Daksh Pharmaceuticals Pvt. Ltd.
  • 18.10. Danone S.A.
  • 18.11. GlaxoSmithKline plc
  • 18.12. Johnson & Johnson Services, Inc.
  • 18.13. Kenvue Inc.
  • 18.14. Macleods Pharmaceuticals Limited
  • 18.15. Merck & Co., Inc.
  • 18.16. Nestle S.A.
  • 18.17. Novartis AG
  • 18.18. Otsuka Pharmaceutical Co., Ltd.
  • 18.19. PepsiCo, Inc.
  • 18.20. Pfizer Inc.
  • 18.21. Sanofi S.A.
  • 18.22. Sun Pharmaceutical Industries Limited
  • 18.23. Unilever PLC
  • 18.24. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORAL REHYDRATION SALTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ORAL REHYDRATION SALTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY BULK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY BULK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY BULK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PREFILLED POUCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PREFILLED POUCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PREFILLED POUCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 1 GRAM SACHET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 1 GRAM SACHET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 1 GRAM SACHET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 2 GRAM SACHET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 2 GRAM SACHET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 2 GRAM SACHET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 4 GRAM SACHET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 4 GRAM SACHET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY 4 GRAM SACHET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY READY-TO-USE LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY READY-TO-USE LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY READY-TO-USE LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CHOLERA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CHOLERA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CHOLERA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY DIARRHEA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY DIARRHEA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY DIARRHEA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SPORTS & EXERCISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SPORTS & EXERCISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SPORTS & EXERCISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ONLINE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY ONLINE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ORAL REHYDRATION SALTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ORAL REHYDRATION SALTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY SACHET, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ORAL REHYDRATION SALTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)